RO7119929, a TLR7 agonist prodrug, induces local inflammation of the tumor microenvironment (TME) by reprogramming myeloid cells in patients (pts) with advanced primary or metastatic liver cancers

被引：1
|
作者：
Fabregat-Franco, Carles
Yoo, Changhoon
Sangro, Bruno
Qvortrup, Camilla
Kim, Hyung-Don
Macarulla, Teresa
Ponz-Sarvise, Mariano
Lin, Chia-Chi
Oh, Do-Youn
Yau, Thomas
Bessa, Juliana
Schwalie, Petra C.
Dettling, Steffen
Schlenker, Ramona
Riede, Natascha
Hall, Elia
Lichtenegger, Felix
Kratochwil, Nicole
Poschinger, Thomas
Jiang, Zhiwen
Jiang, Tianyi
Sie, Christina Godfried
Te-Ying, Audrey Yeo
Schiff, Christina
Hoves, Sabine
Cannarile, Michael
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2342
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2342
引用
收藏
页数：3
相关论文
共 1 条
  • [1] Phase 1 study of RO7119929 (TLR7 agonist prodrug) in patients (pts) with advanced primary or metastatic liver cancers
    Yoo, Changhoon
    Verdaguer, Helena
    Lin, Chia-Chi
    Qvortrup, Camilla
    Yau, Thomas
    Oh, Do-Youn
    Lichtenegger, Felix
    Franjkovic, Izolda
    Kratochwil, Nicole
    Bessa, Juliana
    Rossmann, Eva
    Hall, Elia
    Dai, Congqi
    Krieter, Oliver
    Te-Ying, Audrey Yeo
    Cannarile, Michael
    Schiff, Christina
    Sangro, Bruno
    CANCER RESEARCH, 2023, 83 (08)
1